Cargando…

Development of a SMCs model from HGPS-iPS and proofs of principle

Detalles Bibliográficos
Autor principal:	Ferreira, Lino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652490/ http://dx.doi.org/10.1186/1750-1172-10-S2-O3

Ejemplares similares

New therapeutic approaches to HGPS based on progerin inhibition
por: Pellegrini, Camilla
Publicado: (2015)

Pluripotent stem cells for pathological modelling of Hutchinson-Gilford Progeria Syndrome (HGPS) and drug discovery
por: Nissan, Xavier
Publicado: (2015)

A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells
por: Lo Cicero, Alessandra, et al.
Publicado: (2016)

Cyclic GMP signalling in human ES and iPS-derived vascular cells
por: Taura, Daisuke, et al.
Publicado: (2009)

Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes
por: Lo Cicero, Alessandra, et al.
Publicado: (2018)

Accelerated atherosclerosis in HGPS
por: Hamczyk, Magda R., et al.
Publicado: (2018)

Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
por: Namer, Barbara, et al.
Publicado: (2018)

The Effect of Long-Term Passage on Porcine SMCs’ Function and the Improvement of TGF-β1 on Porcine SMCs’ Secretory Function in Late Passage
por: Zheng, Yan-Yan, et al.
Publicado: (2023)

Beyond iPS!
Publicado: (2012)

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
por: Benz, CC
Publicado: (2003)

Antisense-Based Progerin Downregulation in HGPS-Like Patients’ Cells
por: Harhouri, Karim, et al.
Publicado: (2016)

Understanding nanostructure formation from first principles
por: Rauls, Eva
Publicado: (2012)

Modeling Kidney Disease with iPS Cells
por: Freedman, Benjamin S.
Publicado: (2015)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

ChIP-on-chip significance analysis reveals ubiquitous transcription factor binding
por: Margolin, Adam A, et al.
Publicado: (2007)

Folding principles of genomes
por: Dekker, Job
Publicado: (2012)

Folding principles of genomes
por: Dekker, Job
Publicado: (2013)

Ultra-high resolution mapping of protein-genome interactions using ChIP-exo
por: Franklin Pugh, B
Publicado: (2012)

Is a cure for HIV feasible? A proof-of-concept in humanized mice
por: Speck, Roberto
Publicado: (2013)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)

Characterisation of human iPS cells harbouring the p.A329T variant of caspase-1
por: Thiem, J, et al.
Publicado: (2015)

Antimalarial activity of ulein and proof of its action on the Plasmodium falciparum digestive vacuole
por: de Oliveira, Alaíde Braga, et al.
Publicado: (2010)

iPS Cells for Modelling and Treatment of Retinal Diseases
por: Chen, Fred K., et al.
Publicado: (2014)

Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009)

Evolving science enhanced with iPS
Publicado: (2007)

iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016)

MR-Augmented Cardiopulmonary Exercise Testing- a proof of concept in Sickle Cell Disease (SCD)
por: Ako, Emmanuel O, et al.
Publicado: (2016)

Good practice principles for sharing individual participant data from publicly funded clinical trials
por: Smith, Catrin Tudur, et al.
Publicado: (2015)

Development of allogeneic iPS cell‐based therapy: from bench to bedside
por: McKenna, David H, et al.
Publicado: (2022)

Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
por: Lachmann, H, et al.
Publicado: (2015)

Hypoxia induced the differentiation of Tbx18-positive epicardial cells to CoSMCs
por: Jing, Xiaodong, et al.
Publicado: (2016)

An iPS‐derived in vitro model of human atrial conduction
por: Biendarra‐Tiegs, Sherri M., et al.
Publicado: (2022)

OA12 Dactylitis in PsA: aetiology, clinical significance, & treatment implications
por: Melville, Andrew
Publicado: (2022)

O025 Smart polymer implants as an emerging technology for treating airway collapse in obstructive sleep apnea: proof of concept
por: Sideris, A, et al.
Publicado: (2021)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

The tumourigenicity of iPS cells and their differentiated derivates
por: Liu, Zhiqiang, et al.
Publicado: (2013)

iPS-Cinderella Story in Cell Biology
Publicado: (2010)

Questions Surrounding iPS Cells in Japan
por: Yui, Yoshiki
Publicado: (2016)

iPS‐derived pericytes for neurovascular regeneration
por: Kirabali, Tunahan, et al.
Publicado: (2021)

Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS
por: Kim, Bae-Hoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ejh45rq5he24kakfo61irraf66